The future of metabolomics in ELIXIR

Title: The future of metabolomics in ELIXIR
Authors: Steinbeck, C
Van Rijswijk, M
Beirnaert, C
Caron, C
Cascante, M
Dominguez, V
Dunn, WB
Ebbels, TMD
Giacomoni, F
Gonzalez-Beltran, A
Hankemeier, T
Haug, K
Izquierdo-Garcia, JL
Jimenez, RC
Jourdan, F
Kale, N
Klapa, MI
Kohlbacher, O
Koort, K
Kultima, K
Le Corguillé, G
Moschonas, NK
Neumann, S
O'Donovan, C
Reczko, M
Rocca-Serra, P
Rosato, A
Salek, RM
Sansone, SA
Satagopam, V
Schober, D
Shimmo, R
Spicer, RA
Spjuth, O
Thévenot, EA
Viant, MR
Weber, RJM
Willighagen, EL
Zanetti, G
Item Type: Journal Article
Abstract: Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the "Future of metabolomics in ELIXIR" was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established metabolite identification as the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.
Issue Date: 30-Oct-2017
Date of Acceptance: 6-Sep-2017
ISSN: 2046-1402
Publisher: F1000 Research Ltd
Journal / Book Title: F1000Research
Volume: 6
Copyright Statement: Copyright: © 2017 van Rijswijk M et al. This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
Sponsor/Funder: Commission of the European Communities
European Molecular Biology Laboratory
Funder's Grant Number: 312941
Publication Status: Published
Open Access location:
Article Number: 1649
Appears in Collections:Division of Surgery

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons